The Cardiovascular Research Center
Founded in 2007, the Cardiovascular Research Center is home to scientists, physician-scientists, medical/graduate, and undergraduate students focused on basic and translational cardiovascular research. Investigators from various disciplines, including biomedical engineering, development biology, vascular biology, and pharmacogenomics, join their talents here to pursue cross-disciplinary goals using fundamental discoveries to prevent and reverse heart failure and atherosclerosis.
Engineered Cardiac Tissue Developed to Study the Human Heart
February 2, 2014 - Researchers show their human engineered cardiac tissue may provide a reliable surrogate for human myocardium to improve preclinical therapeutic testing.
Long-Lasting Gene Therapy Benefits Advanced Heart Failure Patients
November 19, 2013 - Cardiovascular Research Center at Mount Sinai report promising long-term follow-up results for its single dose AAV1/SERCA2a gene therapy in advanced heart failure patients.
For more information about our Center, contact:
Roger J. Hajjar, MD is Director of the Cardiovascular Research Center at Icahn School of Medicine and the Arthur & Janet C. Ross Professor of Medicine.